Rezatapopt is an antineoplastic agent, used to inhibit solid tumor with p53 mutation.
References:
[1]. Li Sujing, et al. Heteroarylalkyne compounds for targeting mutant of p53 and their preparation. World Intellectual Property Organization, WO2023016434 A1. 2023-02-16.
















